Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.84
-$0.21-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.54M | -67.51M | -57.95M | -50.29M | -40.21M |
| Total Depreciation and Amortization | 233.00K | 318.00K | 420.00K | 517.00K | 588.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 76.00K | 208.00K | 396.00K |
| Total Other Non-Cash Items | 4.69M | 4.95M | 5.01M | 4.41M | 3.01M |
| Change in Net Operating Assets | 9.12M | 2.74M | -5.46M | -5.09M | -5.58M |
| Cash from Operations | -64.49M | -59.51M | -57.90M | -50.25M | -41.79M |
| Capital Expenditure | -7.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.63M | 64.23M | 29.23M | -4.95M | -121.31M |
| Cash from Investing | -1.64M | 64.23M | 29.23M | -4.95M | -121.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -10.90M | -13.16M | -15.48M |
| Issuance of Common Stock | 77.43M | 2.85M | 35.94M | 73.17M | 182.07M |
| Repurchase of Common Stock | -- | -13.00K | -13.00K | -13.00K | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.43M | 2.84M | 25.03M | 60.00M | 166.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.29M | 7.56M | -3.64M | 4.80M | 3.47M |